AIM ImmunoTech (AIMI) Stock Statistics & Valuation Metrics

AIM ImmunoTech has a market cap or net worth of $5.12M. The enterprise value is ―.

AIM ImmunoTech has 764,239 shares outstanding. The number of shares has decreased by -2.65% in one year.

AIM ImmunoTech’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, AIM ImmunoTech had revenue of ― and earned ― in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

AIM ImmunoTech pays an annual dividend of $0.272, resulting in a dividend yield of ―

AIM ImmunoTech upcoming earnings date is Aug 19, 2025, TBA (Confirmed).

AIM ImmunoTech as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, AIM ImmunoTech has paid ― in taxes.

AIM ImmunoTech EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

AIM ImmunoTech has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for AIM ImmunoTech is $1.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy